Single Stage CABG and Peripheral Arterial Bypass for Combined Coronary and Peripheral Arterial Disease Divya Arora, Ashok Chahal and Shamsher Singh Lohchab.

Slides:



Advertisements
Similar presentations
Off pump CABG has been performed for the first time 40 years ago. Although conventional CABG is considered both safe and effective, the use of CBP.
Advertisements

PAD Rehabilitation Toolkit A Guide for Healthcare Professionals Healthy Steps for Peripheral Artery Disease (PAD) Developed by AACVPR and the Vascular.
Evolving Strategies in the Treatment of Peripheral Vascular Disease Ravish Sachar MD, FACC Wake Heart and Vascular.
Single Center Experience with Drug Eluting Stents for Infrapopliteal Occlusive Disease in Patients with Critical Limb Ischemia: Mid-term follow up Robert.
Arterial ischemia – acute and chronic. Principles of Surgery lecture series 18 October 2011 Barry Rubin MD PhD FRCSC Vascular Surgery UHN.
Coronary Revascularisation in Patients With Diabetes Mellitus Dr Rod Stables The Cardiothoracic Centre Liverpool UK.
Can we prevent stent restenosis after coronary stent implantation
Asymptomatic Carotid Surgery Trial ACST-2 Collaborators Meeting 2014 Pembroke College, Oxford Is recent coronary stenting a problem (or an opportunity)
Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery 2007 ACC/AHA and 2009 ESC GUIDELINES.
Leadership. Knowledge. Community. Canadian Cardiovascular Society Antiplatelet Guidelines Antiplatelet Therapy for Vascular Prevention in Patients with.
C.H.T Dr.Salarifar 1 Tehran Heart Center Tehran University of Medical Sciences PCI VS CABG M. SALARIFAR, MD.
Simultaneous Coronary Artery Bypass and Carotid Endarterectomy Ye zhidong, Liu Peng Department of Cardiovascular Surgery China-Japan Friendship Hospital.
One stage coronary and peripheral intervention Pawel Buszman, MD, American Heart of Poland, Ustron Silesian Medical School, Katowice.
Published in Circulation 2005 Percutaneous Coronary Intervention Versus Conservative Therapy in Nonacute Coronary Artery Disease: A Meta-Analysis Demosthenes.
Rashad MAHMUDOV Central Hospital of Oilworkers, Baku-Azerbaijan
New ESC/EACTS guidelines on myocardial revascularisation Indications for coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention.
1 1 The Use of Percutaneous Coronary Intervention in Patients with Class I Indications for Coronary Artery Bypass Graft Surgery: Data from the National.
SCAAR UCR SWEDEN 2007 Stefan James, Jörg Carlsson, Johan Lindbäck, Tage Nilsson, Ulf Stenestrand, Lars Wallentin and Bo Lagerqvist for the SCAAR study.
Coronary Artery Disease in Diabetic Patients, Different from Non-diabetics?
Stent or Surgery: What is Best for a Woman ? Dr R H Stables Cardiothoracic Centre Liverpool UK.
Peripheral Arterial Disease Mohammed Al-Omran, MD, MSc, FRCSC Assistant Professor & Consultant Vascular Surgery King Saud University.
RITA-3 Is this a benign lesion in a benign condition? Who Needs Angioplasty in 2008? Stable Angina Stable Angina Keith A A Fox Professor of Cardiology.
Disclosures The presenter has no financial involvement with the product or competing products being discussed. The presenter received travel and lodging.
G. Rainey Williams Symposium September 30, 2005 CABG in the Elderly Patient: On or Off pump? A Single Center Experience R. Nathan Grantham, M.D.
LONG-TERM OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: INITIAL CLINICAL EXPERIENCE. Graidis Ch. 1,
Dr C Raghu Interventional Cardiologist
AB 1/03 Non-Coronary Intervention Circulatory Support Advanced Angioplasty 2003 Andreas Baumbach Bristol Royal Infirmary.
Is the Decision-Making after Failure of CTO Angioplasty Same? Infarct Related CTO or Non- Infarct Related CTO (Continue the Procedure in Other Vessel or.
Multivessel Coronary Artery Disease
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Cardiovascular Surgery J Am Coll Cardiol.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Scope of Coronary Heart Disease in Patients With.
CABG IN DIABETICS DR. SEYED SAEED FARZAM. Introduction Patients with diabetes mellitus Increased incidence of CAD More extensive disease at angiography.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate.
Choosing Wisely: Cardiology Jeffrey Ziffra D.O. Mercy Medical Center – North Iowa 10/14/2016.
Subgroup analyses for mortality after treatment with coronary artery bypass graft (CABG) or percutaneous coronary intervention (PCI). LAD, left anterior.
Anticoagulation after peripheral Vascular Intervention
Multi Modality Approach to Diagnosis of Ischemia in Post CABG Cases
Final Five-Year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients With Three-Vessel Disease and/or Left Main Disease Patrick.
Thirty-day Readmissions Following CABG Surgery in New York JACC: Cardiovascular Interventions 2011;4(5): Hannan EL, Zhong Y, Lahey SJ, Culliford.
CABG in diabetics: surgical aspects
NORSTENT Trial design: Patients with obstructive coronary artery disease were randomized to a drug-eluting stent (DES) (n = 4,504) versus a bare-metal.
Figure 3 One-year adverse events (death, post-discharge myocardial infarction, revascularization) after PCI according to patients who (A) would not have.
Patient populations by study group figure 10
The Winking Saphenous Vein Graft: Acute Aorto-Vein Graft Anastomotic Torsional Kink causing Dynamic Systolic Compression Complicating Vein Graft PCI Dr.
Successful CTO PCI Associated with Lower Mortality Risk
Debate: What Does the Future Hold for the Treatment of Unprotected Left Main Disease? More PCI No More Routine Surgery Ron Waksman, MD, FACC Washington.
Andre Lamy on behalf of the COMPASS Investigators
The Hidden Cost of Underutilizing PCI for Chronic Total Occlusions
Glenn N. Levine et al. JACC 2016;68:
Diabetes mellitus in patients undergoing percutaneous drug-eluting stent implantation: short and long-term results Claudio Moretti, M.D. Division of Cardiology,
Section 5: Intervention and drug therapy
Fewer PCIs After Public Reporting Changes in NY
Peter K. Smith, MD  The Journal of Thoracic and Cardiovascular Surgery 
Peter K. Smith, MD  The Annals of Thoracic Surgery 
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Effect of PCI on 1-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval (bars);
% Heparin + GPI IIb/IIIa Bivalirudin +
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Maintenance of Long-Term Clinical Benefit with
DEScover: One-Year Clinical Results
Atlantic Cardiovascular Patient Outcomes Research Team
Sirolimus Stent vs. Bare Stent in Acute Myocardial Infarction Trial
Cox regression of proportion mortality in the first 8 years for patients with three-vessel disease with a significant difference between the treatment.
Glenn N. Levine et al. JACC 2011;58:e44-e122
Lee A. Fleisher et al. JACC 2014;64:e77-e137
Effect of PCI on 3 to 5-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval.
Axillary-Bi-Femoral and Axillary-Uni-Femoral Artery Grafts Have Similar Perioperative Outcomes and Patency Thomas W. Cheng1, M.S., Scott Hardouin1, M.D.,
P2Y12 receptor inhibitor therapy for secondary prevention of patients with stable coronary artery disease. P2Y12 receptor inhibitor therapy for secondary.
Cardiovascular Epidemiology and Epidemiological Modelling
Proposed future revascularisation strategy in patients with ESRD based on our current results and previous guideline recommendations. Proposed future revascularisation.
Presentation transcript:

Single Stage CABG and Peripheral Arterial Bypass for Combined Coronary and Peripheral Arterial Disease Divya Arora, Ashok Chahal and Shamsher Singh Lohchab Pt B D Sharma PGIMS Rohtak Haryana NCR Delhi

Disclosures NONE

Introduction Peripheral arterial disease and coronary artery disease often coexist former indicator of systemic atherosclerosis Ouriel K. Peripheral arterial disease. Lancet 2001;358:1257–1264. Majority of patients with lower extremity PAD requiring surgery have significant CAD. The prevalence of serious angiographic CAD ranges from 37% to 78% in patients undergoing operation for peripheral arterial disease. J Am Coll CardioI1991;18:203-14

Introduction All-cause mortality for combined lower-extremity PAD and CAD is approximately twice as high as that resulting from either of the individual conditions. Management of combined disease a challenge many controversial issues for optimal treatment strategy.

Challenge It seems … to be one of those simple cases which are so extremely difficult. Sherlock Holmes

Options Peripheral artery bypass and medical management of CAD PCI and Peripheral artery bypass Not suitable for PCI option remains simultaneous surgery for both.

Peripheral bypass and medical management of CAD Intra-operative and post-operative surveillance for myocardial ischaemia, infarction, and arrhythmias is important since peri- operative MI has been associated with 30–50% peri-operative mortality and reduced long-term survival. Fleisher LA et al.Circulation 2009;120:e169-e276

PCI and Peripheral artery bypass If revascularization by PCI is performed, postponing non-urgent vascular surgery for 14 days at least 6 weeks but preferably 3 months after bare metal stent. Fleisher LA Circulation 2009;120:e169-e276 Poldermans D et al. Eur Heart J 2009;30:2769-2812 1 year after drug-eluting stent, is recommended to decrease the risk of coronary/stent thrombosis peri-operatively Nuttall GA et al. Anesthesiology 2008;109:588-595 Anesthesiology 2008;109:596-604.

Peri-operative and long-term morbidity and mortality in patients undergoing non-cardiac vascular surgery with combined coronary artery disease Peri-operative  Eagle et al. Increased cardiac events from 3 to 8.5% after non-cardiac vascular surgery Coronary Artery Surgery Study. Circulation 1997;96:1882- 1887.pmid:9323076 Late Farkouh et al. Decreased survival at 10 years (24 vs. 51%) and increased cardiac events at 5 years (50 vs. 28%) after lower extremity vascular surgery J Am Coll Cardiol 1994;24:1290-1296.

Dilemma Patients Presenting with severe claudication and limb threatening ischemia deny coronary symptoms as unable to walk Execise ECG not feasible Stress Echo and CAG If significant CAD found do not want CABG due to denial of symptoms of CAD

Methods From January 2014 to August 2016 36 patients all males mean age 62 ± 7 years range 45 to 73 years underwent concomitant off pump CABG and peripheral arteria bypass These patients presented with severe lower limb ischemia Lower extremity CT angiography demonstrated Infra renal aortoiliac disease in 9(25%) patients Isolated external iliac occlusion in 12 (33%) superficial femoral artery occlusion in 15 (42%)

Methods CAG- Significant double vessel coronary occlusion was found in 12(33%) Triple coronary disease in 24 (67%) LV dysfunction was there in 24 (50%). There were 9(25%) diabetic patients

Strategy for aortoiliac disease was single stage abdominal aortobifemoral bypass grafting first followed by off pump CABG keeping in view the need for IABP.

Strategy For isolated iliac artery disease –Cross over femorofemoral bypass after completion of CABG. For superficial femoral artery, Femoropopliteal bypass after completion of CABG.

Results The operative mortality observed was in 2/36 (5.5%) Postoperative complications observed were acute limb ischemia in 1/36 (2.7%). Renal failure 2/36 (5.5%). None of these patients required rexploration for excessive bleeding. Two patients required IABP support and in one patient the catheter was put through the one limb of aortobifemoral femoral graft 30/34 (88%) patients were asymptomatic at maximum follow up of 32 months range (3-32).

Conclusion Single stage off pump CABG and peripheral artery bypass can be performed safely and obviates the major cardiovascular events in patients presenting with severe lower extremity ischemia.